Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-09

Clinical Trial Update: Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites [NA]

View source ↗

Summary

Clinical trial exploring how ZhenQiFuZheng may treat allergic rhinitis by influencing gut microbiota and metabolites. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZhenQiFuZheng

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Rhinitis, Allergic | NA | Status: RECRUITING